Company Overview of Replicon Technologies, Inc.
Replicon Technologies, Inc. develops replicons, non-replicating RNA viral particles, and a patented procedure to encapsulate them into virus-like particles for the large-scale growth and purification required for therapeutic applications. Replicon Technologies, Inc. was founded in 1997 and is based in Birmingham, Alabama.
2800 Milan Court
Birmingham, AL 35211-6973
Founded in 1997
Key Executives for Replicon Technologies, Inc.
Replicon Technologies, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Replicon Technologies, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.